Compare VABK & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VABK | QSI |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.3M | 194.8M |
| IPO Year | 2013 | N/A |
| Metric | VABK | QSI |
|---|---|---|
| Price | $43.40 | $0.99 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 2.9K | ★ 6.5M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | ★ 12.70 | N/A |
| EPS | ★ 0.97 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $618.07 |
| P/E Ratio | $43.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $36.48 | $0.69 |
| 52 Week High | $48.58 | $3.10 |
| Indicator | VABK | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 45.26 |
| Support Level | $37.99 | $0.87 |
| Resistance Level | $48.58 | $1.08 |
| Average True Range (ATR) | 0.75 | 0.11 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 100.00 | 28.97 |
Virginia National Bankshares Corp is a bank holding company engaged in commercial and retail banking. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and other depository services. Its segments include the Bank, VNB Trust and Estate Services, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits, and offering related services to individuals, businesses, and charitable organizations.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.